Pai-Sheng Chen,Jie-Ning Li,Yao-Lung Kuo,Ming-Yang Wang
申请号：
US16209907
公开号：
US20190277850A1
申请日:
2018.12.04
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention provides a method of evaluating drug resistance in hormone therapy including the following steps. Firstly, a primary level of TRBP in a subject is measured, and an effective amount of tamoxifen, an active form of tamoxifen or an analogous of tamoxifen is provided to the subject. Then, a level of TRBP in the subject is measured after providing tamoxifen, the active form of tamoxifen or the analogous of tamoxifen. Finally, a level change of TRBP in the subject is discriminated to determine a tamoxifen resistance.
